SCHEMBL14680905

SCHEMBL14680905

CCCCCCc1cc(-c2cc(-c3ccc(-c4ccncc4)c(CCCCCC)c3)c(-c3ccc(-c4ccncc4)c(CCCCCC)c3)cc2-c2ccc(-c3ccncc3)c(CCCCCC)c2)ccc1-c1ccncc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.41
CYP2D6 P10635 1/20 0.41
RARB P10826 2/20 0.37
MAPT P10636 3/20 0.37
TSHR P16473 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
MEN1 O00255 1/20 0.37
TP53 P04637 1/20 0.37
ALOX5 P09917 1/20 0.37
TYR P14679 1/20 0.37
ALOX15 P16050 1/20 0.37
HTT P42858 1/20 0.37
KMT2A Q03164 1/20 0.37
TLR8 Q9NR97 1/20 0.36
NPC1 O15118 2/20 0.36
ALDH1A1 P00352 2/20 0.36
RAB9A P51151 2/20 0.36
GSK3B P49841 1/20 0.36
NFKB1 P19838 1/20 0.36
S1PR1 P21453 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14680959 0.83 CNR1 (0.51) CYP3A4CYP2D6TDP1TLR8LMNA
Water SCHEMBL28833009 0.82 TYR (0.43) CYP3A4RARBMAPTTSHRTDP1
Methyl Alcohol SCHEMBL27900235 0.80 TYR (0.46) CYP3A4RARBMAPTTSHRTDP1
SCHEMBL24115201 0.78 TDP1 (0.46) CYP3A4CYP2D6MAPTTSHRTDP1
SCHEMBL14680982 0.77 CYP1A2 (0.47) CYP2D6GPR3LIPG
Bromide SCHEMBL30074237 0.76 CYP3A4 (0.49) CYP3A4CYP2D6RARBMAPTTSHR
SCHEMBL10429729 0.76 LIPG (0.45) RARBGPR3LIPG
Hydrogen Sulfide SCHEMBL3280224 0.76 TYR (0.42) CYP3A4RARBMAPTTSHRTDP1
SCHEMBL19854385 0.75 TP53 (0.54) CYP3A4MAPTTSHRTDP1MEN1
SCHEMBL19854457 0.75 TP53 (0.54) CYP3A4MAPTTSHRTDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796461-B2 1,2,4,5-substituted phenyl compound, method for producing same and organic electroluminescent device comprising same as constituent TOSOH CORPORATION (JP) 2014-08-05 US disclosed
US-20130035491-A1 1,2,4, 5-SUBSTITUTED PHENYL COMPOUND, METHOD FOR PRODUCING SAME AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME AS CONSTITUENT TOSOH CORPORATION (JP) 2013-02-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130035491-A1 1,2,4, 5-SUBSTITUTED PHENYL COMPOUND, METHOD FOR PRODUCING SAME AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME AS CONSTITUENT XDH, OR10J3, HAX1 CYP3A4 323/4885CYP2D6 992/4885RARB 4689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.